KRAS and neoplasm: identified for the first-time polyclonal reactivity of CD8+ TILs against KRAS G12D in TILs from a patient with colorectal carcinoma carrying the G12D mutation and HLA- C*08:02, after infusion of expanded TILs, which achieved objective tumor regression in multiple pulmonary metastases (89).